Efficacy and Safety of Venetoclax in Combination with Gilteritinib for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia in the Expansion Cohort of a Phase 1b Study

被引：23
|
作者：
Daver, Naval
Altman, Jessica K.
Maly, Joseph
Levis, Mark
Ritchie, Ellen
Litzow, Mark
McCloskey, James K.
Smith, Catherine C.
Schiller, Gary J.
Bradley, Terrence
Tiu, Ramon V.
Hong, Wan-Jen
Tong, Bo
Qin, Qin
Dilley, Kimberley
Perl, Alexander E.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-139705
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Efficacy and Safety of Venetoclax in Combination with Gilteritinib for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: Updated Analyses of a Phase 1b Study
    Altman, Jessica K.
    Daver, Naval
    Maly, Joseph
    Levis, Mark
    Ritchie, Ellen
    Litzow, Mark
    McCloskey, James
    Smith, Catherine C.
    Schiller, Gary
    Bradley, Terrence
    Tiu, Ramon V.
    Naqvi, Kiran
    Siddani, Satya
    Wang, Jing
    Lee, Paul
    Perl, Alexander E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S285 - S285
  • [2] Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia
    Daver, Naval
    Perl, Alexander E.
    Maly, Joseph
    Levis, Mark
    Ritchie, Ellen
    Litzow, Mark
    McCloskey, James
    Smith, Catherine C.
    Schiller, Gary
    Bradley, Terrence
    Tiu, Ramon, V
    Naqvi, Kiran
    Dail, Monique
    Brackman, Deanna
    Siddani, Satya
    Wang, Jing
    Chyla, Brenda
    Lee, Paul
    Altman, Jessica K.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (35) : 4048 - +
  • [3] Gilteritinib with or without venetoclax for relapsed/refractory FLT3-mutated acute myeloid leukaemia
    Kugler, Eitan
    Cohen, Inbar
    Amitai, Irina
    Ram, Ron
    Frisch, Avraham
    Nachmias, Boaz
    Canaani, Jonathan
    Moshe, Yakir
    Krayem, Baher
    Aumann, Shlomzion
    Henig, Israel
    Vainstein, Vladimir
    Shargian, Liat
    Ganzel, Chezi
    Yeshurun, Moshe
    Levi, Itay
    Raanani, Pia
    Akria, Luiza
    Ofran, Yishai
    Shimony, Shai
    Wolach, Ofir
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (03) : 932 - 941
  • [4] Gilteritinib for the treatment of relapsed and/or refractory FLT3-mutated acute myeloid leukemia
    McMahon, Christine M.
    Perl, Alexander E.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (09) : 841 - 849
  • [5] Venetoclax in Combination with Gilteritinib in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Phase 1b Study
    Perl, Alexander E.
    Daver, Naval G.
    Pratz, Keith W.
    Maly, Joseph
    Hong, Wan-Jen
    Bahceci, Erkut
    Tong, Bo
    Tian, Tian
    Dilley, Kimberley
    BLOOD, 2019, 134
  • [6] Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia
    McMahon, Christine M.
    Canaani, Jonathan
    Rea, Bryan
    Sargent, Rachel L.
    Qualtieri, Julianne N.
    Watt, Christopher D.
    Morrissette, Jennifer J. D.
    Carroll, Martin
    Perl, Alexander E.
    BLOOD ADVANCES, 2019, 3 (10) : 1581 - 1585
  • [7] Gilteritinib and Venetoclax for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia - a Real-World Multicenter Retrospective Study
    Kugler, Eitan
    Cohen, Inbar
    Ram, Ron
    Canaani, Jonathan
    Amitai, Irina
    Shargian, Liat
    Nachmias, Boaz
    Krayem, Baher
    Frisch, Avraham
    Levi, Itay
    Akria, Luiza
    Raanani, Pia
    Wolach, Ofir
    Kugler, Eitan
    BLOOD, 2023, 142
  • [8] Iadademstat and Gilteritinib for the Treatment of FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia: The Frida Study
    Fathi, Amir T.
    Braun, Theodore P.
    Ambinder, Alexander Joseph
    Borthakur, Gautam
    Redner, Robert L.
    Arevalo, Mabel
    Gutierrez, Sonia
    Limon, Ana
    Faller, Douglas V.
    BLOOD, 2023, 142
  • [9] Gilteritinib: A Review in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukaemia
    Connie Kang
    Hannah A. Blair
    Targeted Oncology, 2020, 15 : 681 - 689
  • [10] Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia
    Hosono, Naoko
    Yokoyama, Hisayuki
    Aotsuka, Nobuyuki
    Ando, Kiyoshi
    Iida, Hiroatsu
    Ishikawa, Takayuki
    Usuki, Kensuke
    Onozawa, Masahiro
    Kizaki, Masahiro
    Kubo, Kohmei
    Kuroda, Junya
    Kobayashi, Yukio
    Shimizu, Takayuki
    Chiba, Shigeru
    Nara, Miho
    Hata, Tomoko
    Hidaka, Michihiro
    Fujiwara, Shin-Ichiro
    Maeda, Yoshinobu
    Morita, Yasuyoshi
    Kusano, Mikiko
    Lu, Qiaoyang
    Miyawaki, Shuichi
    Berrak, Erhan
    Hasabou, Nahla
    Naoe, Tomoki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (11) : 2131 - 2141
12345